News
As demand for obesity drugs rises, questions emerge over approvals granted without India-specific safety and efficacy trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback